Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To confirm the efficacy of SIAC OD + metformin in controlling glycaemia with respect to change from baseline in HbA1c after 26 weeks of treatment. This is done by comparing the difference in change from baseline in HbA1c after 26 weeks of treatment between SIAC OD + metformin and insulin glargine OD + metformin to a non-inferiory limit of 0.4%, and if non-inferiority is confirmed to a superiority limit of 0%.
Critère d'inclusion
- Type 2 Diabetes